Gatifloxacin: A new fluoroquinolone for use in community-acquired pneumonia and other infections

Gatifloxacin is a fluoroquinolone antimicrobial agent that is active against a number of gram-positive and gram-negative pathogens. Pending FDA approval, this drug could have a role in treating community-acquired pneumonia.

Saved in:
Bibliographic Details
Published in:Formulary (Cleveland, Ohio) Ohio), 1999-12, Vol.34 (12), p.1002
Main Authors: Preston, Sandra L, Drusano, George L
Format: Article
Language:English
Subjects:
Antibiotics
FDA approval
Pharmacology
Pneumonia
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Gatifloxacin is a fluoroquinolone antimicrobial agent that is active against a number of gram-positive and gram-negative pathogens. Pending FDA approval, this drug could have a role in treating community-acquired pneumonia.
ISSN:1082-801X
1938-1166